Associate Director, FP&A

Accountabilities

• Own the annual budgeting process, quarterly reforecasts, and long-range financial planning, including consolidated operating expense, headcount, and cash flow models.

• Develop and maintain cash runway and burn rate forecasts, incorporating scenario and sensitivity analyses linked to clinical development timelines and funding requirements.

• Partner with Clinical Operations to translate enrollment assumptions, site activation plans, CRO contracts, and contract changes into clinical program expense forecasts and cash flow projections.

• Support headcount and personnel cost planning, including stock-based compensation assumptions, in collaboration with HR and Accounting.

• Serve as the primary FP&A partner to clinical program teams and functional leaders, integrating financial insights into operational planning and day-to-day decision-making.

• Evaluate strategic opportunities, investment trade-offs, and resource allocation priorities, challenging assumptions and supporting financially disciplined decisions.

• Identify emerging financial risks and opportunities, communicate them proactively, and recommend practical solutions.

• Prepare monthly, quarterly, and annual financial reporting packages for the CFO, senior leadership, and Board of Directors, including budget-to-actual variance analysis and explanations of key financial drivers.

• Support the accounting close process, working with Accounting on clinical trial accruals and other research and development expenses.

• Prepare financial analyses and supporting schedules for external reporting, including quarterly and annual SEC filings and earnings materials, in coordination with Accounting, Legal, and Investor Relations.

• Maintain accuracy and consistency across financial models, source systems, forecasts, and reporting deliverables.

• Improve financial planning systems, reporting capabilities, and analytics, evaluating planning platforms and clinical trial financial management tools where appropriate.

• Promote the use of AI and automation to streamline recurring FP&A activities, reduce manual work, and increase capacity for strategic analysis.

• Document and enhance financial planning and reporting processes to support future clinical milestones, potential regulatory submissions, and commercial launch preparation.

• Communicate financial findings and recommendations clearly to stakeholders with varying levels of financial expertise.

Requirements:

• Bachelor’s degree in Finance, Accounting, Economics, or a related field.

• At least 10 years of progressive experience in FP&A or corporate finance, including a minimum of 5 years supporting biotechnology or pharmaceutical research and development.

• Advanced Excel and financial modeling skills, with demonstrated ownership of operating expense and cash forecasting models from initial development through executive and Board-level presentations.

• Working knowledge of US GAAP, financial forecasting methodologies, clinical program accruals, and R&D expense recognition.

• Experience supporting public company reporting cycles, including quarterly close processes, SEC filing inputs, and Board reporting.

• Proven ability to influence cross-functional stakeholders, build effective business partnerships, and communicate financial insights to senior executives.

• Strong analytical and problem-solving skills, with the ability to evaluate complex financial scenarios, identify risks, and recommend resource allocation decisions.

• Ability to work independently, navigate ambiguity, and build effective financial processes in a small, fully remote organization with limited infrastructure.

• Excellent organizational skills, attention to detail, and a commitment to maintaining reliable financial data and reporting accuracy.

• An MBA, CPA, or CFA designation is preferred.

• Experience with NetSuite or a comparable ERP system and financial planning platforms such as Workday Adaptive Planning, Vena, Planful, or Anaplan is an advantage.

• Familiarity with clinical trial financial management tools, such as Condor or Auxilius, and clinical source systems such as CTMS, EDC, or IRT is desirable.

• Experience applying AI and automation tools to financial analysis, reporting, and business decision-making is beneficial.

• Experience supporting a company through a Phase 3 clinical readout, New Drug Application (NDA) submission, or commercial launch preparation is a plus.

• Must be legally authorized to work in the United States. Applicants should note that the application process asks whether current or future visa sponsorship will be required.

• Willingness to travel less than 10% for leadership meetings, Board meetings, and industry conferences.

Benefits:

• Annual base salary of$165,000–$195,000.

• Fully remote work within the United States.

• Opportunities to influence strategic financial decisions in a clinical-stage biopharmaceutical organization.

• Exposure to executive leadership, Board-level reporting, and financial planning for clinical development programs.

• Opportunities to improve financial systems, introduce automation, and shape scalable planning processes.

• Limited business travel, expected to be less than 10% annually.